Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Equity: 2020-2025

Historic Return on Equity for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to 0.20%.

  • Harmony Biosciences Holdings' Return on Equity changed negligibly% to 0.20% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.20%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 0.21% for FY2024, which is 6.00% down from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Return on Equity stood at 0.20%, which was down 4.23% from 0.20% recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Return on Equity ranged from a high of 0.51% in Q3 2022 and a low of 0.09% during Q1 2021.
  • Over the past 3 years, Harmony Biosciences Holdings' median Return on Equity value was 0.20% (recorded in 2025), while the average stood at 0.26%.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 58bps in 2021, then fell by 24bps in 2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Return on Equity (Quarterly) stood at 0.19% in 2021, then increased by 29bps to 0.49% in 2022, then declined by 24bps to 0.24% in 2023, then decreased by 6bps to 0.19% in 2024, then remained steady at 0.20% in 2025.
  • Its Return on Equity was 0.20% in Q3 2025, compared to 0.20% in Q2 2025 and 0.18% in Q1 2025.